CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
i-gel airway (Intersurgical Ltd., Wokingham, England) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00706823
NCT00706823N/ACompleted
CompareCT.gov

A Randomized Clinical Comparison of the Intersurgical I-gel and the Laryngeal Mask Airway Unique in Non-Obese Adult Patients During General Surgery

The University of Texas Health Science Center, Houston·interventional·Posted Jun 30, 2008·Updated Feb 20, 2017

In Brief

A clinical study evaluating i-gel airway (Intersurgical Ltd., Wokingham, England) and Laryngeal Mask Airway-Unique for Endotracheal Intubation and Supraglottic Airway. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate a new disposable supra-glottic airway device, the i-gel airway (Intersurgical Ltd., Wokingham, England). We propose to test its ease of insertion, position within the airway, drain tube patency and anatomic sealing properties during mechanical ventilation in non-obese anesthetized patients undergoing elective general surgery. The study device will be compared to the current standard in the industry, the LMA Unique.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndotracheal Intubation, Supraglottic Airway
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 30, 2008
Enrollment StartFeb 1, 2008
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.0 years ago

Interventions

i-gel airway (Intersurgical Ltd., Wokingham, England)device

supra-glottic airway device

Laryngeal Mask Airway-Uniquedevice

supra-glottic airway device